PTXnLNP-049

N/A

Report date: 2025/03/20 15:53:57
NME

Base Information

Drug NamePTXnLNP-049
Drug Alias NamemRNA-based gene therapy (Pantherna)mRNA-based gene therapy (Pantherna/Astellas)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLiver DiseasesMuscular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanyJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPantherna Therapeutics GmbH
China Registration ClassN/A

Develop Information

Active CompaniesAstellas Pharma Inc francePantherna Therapeutics GmbH
Inactive CompaniesN/A
Active IndicationsLiver DiseasesMuscular Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A